-
1
-
-
84942370216
-
Unaddressed privacy risks in accredited health and wellness apps: A crosssectional systematic assessment
-
Huckvale K, Prieto JT, Tilney M, Benghozi PJ, Car J. Unaddressed privacy risks in accredited health and wellness apps: A crosssectional systematic assessment. BMC Med. 2015; 13: 214
-
(2015)
BMC Med
, vol.13
, pp. 214
-
-
Huckvale, K.1
Prieto, J.T.2
Tilney, M.3
Benghozi, P.J.4
Car, J.5
-
2
-
-
85061331419
-
-
N Y Times. March 16, 2015. Accessed March 14
-
Krisch JA. Questioning the value of health apps. N Y Times. March 16, 2015. http://well. blogs.nytimes.com/2015/03/16/health-appsprovide-pictures-if-not-proof-of-health/?-r=2. Accessed March 14, 2016
-
(2016)
Questioning the Value of Health Apps
-
-
Krisch, J.A.1
-
7
-
-
84977599799
-
There's an app for that: A guide for healthcare practitioners and researchers on smartphone technology
-
BinDhim NF, Trevena L. There's an app for that: A guide for healthcare practitioners and researchers on smartphone technology. Online J Public Health Inform. 2015; 7: e218
-
(2015)
Online J Public Health Inform
, vol.7
, pp. e218
-
-
BinDhim, N.F.1
Trevena, L.2
-
8
-
-
84938539878
-
Novel methods and technologies for 21st-century clinical trials: A review
-
Dorsey ER, Venuto C, Venkataraman V, Harris DA, Kieburtz K. Novel methods and technologies for 21st-century clinical trials: A review. JAMA Neurol. 2015; 72: 582-588
-
(2015)
JAMA Neurol
, vol.72
, pp. 582-588
-
-
Dorsey, E.R.1
Venuto, C.2
Venkataraman, V.3
Harris, D.A.4
Kieburtz, K.5
-
9
-
-
85009300789
-
-
Lessons from the C-Suite: Dr. John Noseworthy, CEO of Mayo Clinic. Advisory Board Company Web site. July 23, 2014. Accessed March 14
-
Larsen E, Diamond D. Why Mayo Clinic's CEO wants to serve 200 million patients-and how he plans to do it. Lessons from the C-Suite: Dr. John Noseworthy, CEO of Mayo Clinic. Advisory Board Company Web site. July 23, 2014. https://www.advisory.com/daily-briefing/2014/07/23/lessons-fromthe-c-suite-mayo-clinic. Accessed March 14, 2016
-
(2016)
Why Mayo Clinic's CEO Wants to Serve 200 Million Patients-and How He Plans to Do It
-
-
Larsen, E.1
Diamond, D.2
-
10
-
-
61449165975
-
Movement disorder society updrs revision task force movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): Scale presentation and clinimetric testing results
-
Goetz CG, Tilley BC, Shaftman SR, et al; Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008; 23: 2129-2170
-
(2008)
Mov Disord
, vol.23
, pp. 2129-2170
-
-
Goetz, C.G.1
Tilley, B.C.2
Shaftman, S.R.3
-
11
-
-
84929518337
-
Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study
-
Arora S, Venkataraman V, Zhan A, et al. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study. Parkinsonism Relat Disord. 2015; 21: 650-653
-
(2015)
Parkinsonism Relat Disord
, vol.21
, pp. 650-653
-
-
Arora, S.1
Venkataraman, V.2
Zhan, A.3
-
12
-
-
11444261579
-
External validity of randomised controlled trials to whom do the results of this trial apply?
-
Rothwell PM. External validity of randomised controlled trials: To whom do the results of this trial apply? Lancet. 2005; 365: 82-93
-
(2005)
Lancet
, vol.365
, pp. 82-93
-
-
Rothwell, P.M.1
-
13
-
-
33646872630
-
Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants
-
Elting LS, Cooksley C, Bekele BN, et al. Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants. Cancer. 2006; 106: 2452-2458
-
(2006)
Cancer
, vol.106
, pp. 2452-2458
-
-
Elting, L.S.1
Cooksley, C.2
Bekele, B.N.3
-
14
-
-
79955778144
-
Accelerated clinical discovery using selfreported patient data collected online and a patient-matching algorithm
-
Wicks P, Vaughan TE, Massagli MP, Heywood J. Accelerated clinical discovery using selfreported patient data collected online and a patient-matching algorithm. Nat Biotechnol. 2011; 29: 411-414
-
(2011)
Nat Biotechnol
, vol.29
, pp. 411-414
-
-
Wicks, P.1
Vaughan, T.E.2
Massagli, M.P.3
Heywood, J.4
-
15
-
-
84901188360
-
Web-based trial to evaluate the efficacy and safety of tolterodine er 4 mg in participants with overactive bladder: Remote trial
-
Orri M, Lipset CH, Jacobs BP, Costello AJ, Cummings SR. Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial. Contemp Clin Trials. 2014; 38: 190-197
-
(2014)
Contemp Clin Trials
, vol.38
, pp. 190-197
-
-
Orri, M.1
Lipset, C.H.2
Jacobs, B.P.3
Costello, A.J.4
Cummings, S.R.5
-
16
-
-
85018195525
-
Exploring mediators of physical activity in young adult cancer survivors: Evidence from a randomized trial of a facebook-based physical activity intervention
-
Valle CG, Tate DF, Mayer DK, Allicock M, Cai J. Exploring mediators of physical activity in young adult cancer survivors: Evidence from a randomized trial of a facebook-based physical activity intervention. J Adolesc Young Adult Oncol. 2015; 4: 26-33
-
(2015)
J Adolesc Young Adult Oncol
, vol.4
, pp. 26-33
-
-
Valle, C.G.1
Tate, D.F.2
Mayer, D.K.3
Allicock, M.4
Cai, J.5
-
18
-
-
85010854786
-
-
eMarketer eMarketer. October 16 Accessed March 14 2016
-
eMarketer. App marketers focus on engagement, retention. eMarketer. October 16, 2015. http://www.emarketer.com/Article/App-Marketers-Focus-on-Engagement-Retention/1013111. Accessed March 14, 2016
-
(2015)
App Marketers Focus on Engagement, Retention
-
-
|